Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             43 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A comparison of the effects of a chlamydial vaccine administered during or after a C. muridarum urogenital infection of female mice Carey, Alison
2011
29 38 p. 6505-6513
9 p.
artikel
2 Antibody- and cell-mediated immune responses to a synthetic oligosaccharide conjugate vaccine after booster immunization Safari, Dodi
2011
29 38 p. 6498-6504
7 p.
artikel
3 A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors Cheng, Chunmei
2011
29 38 p. 6641-6649
9 p.
artikel
4 Burden of disease and costs of treating rotavirus diarrhea in Mexican children for the period 2001–2006 Granados-García, Víctor
2011
29 38 p. 6712-6719
8 p.
artikel
5 Cell mediated immunity in Legionnaires’ disease Guan, Wang
2011
29 38 p. 6439-6440
2 p.
artikel
6 Cell mediated immunity in Legionnaires’ disease Hoffman, Paul S.
2011
29 38 p. 6437-6438
2 p.
artikel
7 Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection García, Felipe
2011
29 38 p. 6454-6463
10 p.
artikel
8 Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV Liu, Ye V.
2011
29 38 p. 6606-6613
8 p.
artikel
9 Coalition against Typhoid (CaT): A new, global initiative to advance typhoid vaccination Nelson, Christopher B.
2011
29 38 p. 6443-
1 p.
artikel
10 Combined protective effects of anti-PhtD and anti-pneumococcal polysaccharides Denoël, Philippe
2011
29 38 p. 6451-6453
3 p.
artikel
11 Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: Comparing estimates for 7-valent, 10-valent, and 13-valent vaccines Tyo, Karen Richards
2011
29 38 p. 6686-6694
9 p.
artikel
12 Cost-effectiveness of rotavirus vaccination in Bolivia from the state perspective Smith, Emily R.
2011
29 38 p. 6704-6711
8 p.
artikel
13 Defective interfering influenza virus confers only short-lived protection against influenza virus disease: Evidence for a role for adaptive immunity in DI virus-mediated protection in vivo Scott, Paul D.
2011
29 38 p. 6584-6591
8 p.
artikel
14 Editorial Board/Aims and Scope 2011
29 38 p. CO2-
1 p.
artikel
15 Evaluation of cell-mediated immune responses to two BCG vaccination regimes in young children in South Korea Lee, Hyejon
2011
29 38 p. 6564-6571
8 p.
artikel
16 Evaluation of serotype-specific pneumococcal IgG measurement using two different polysaccharides from ATCC and SSI Diagnostica Slotved, Hans-Christian
2011
29 38 p. 6650-6655
6 p.
artikel
17 Evaluation of the immunogenicity and the protective efficacy of a novel identified immunogenic protein, SsPepO, of Streptococcus suis serotype 2 Li, Jinquan
2011
29 38 p. 6514-6519
6 p.
artikel
18 Factors associated with uptake of vaccination against pandemic influenza: A systematic review Bish, Alison
2011
29 38 p. 6472-6484
13 p.
artikel
19 Flagellin produced in plants is a potent adjuvant for oral immunization Girard, Aurélie
2011
29 38 p. 6695-6703
9 p.
artikel
20 Free school-based vaccination with HPV vaccine in a Japanese city Fujiwara, Hiroyuki
2011
29 38 p. 6441-6442
2 p.
artikel
21 Genetic stability of a dengue vaccine based on chimeric yellow fever/dengue viruses Mantel, N.
2011
29 38 p. 6629-6635
7 p.
artikel
22 Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis Garlapati, Srinivas
2011
29 38 p. 6540-6548
9 p.
artikel
23 Immunotherapy in prostate cancer: Emerging strategies against a formidable foe Bilusic, Marijo
2011
29 38 p. 6485-6497
13 p.
artikel
24 Influenza vaccine effectiveness in Wisconsin during the 2007–08 season: Comparison of interim and final results Belongia, Edward A.
2011
29 38 p. 6558-6563
6 p.
artikel
25 Intraperitoneal immunization of recombinant HSP70 (DnaK) of Salmonella Typhi induces a predominant Th2 response and protective immunity in mice against lethal Salmonella infection Paliwal, Piyush Kumar
2011
29 38 p. 6532-6539
8 p.
artikel
26 Natural products and the search for novel vaccine adjuvants Rey-Ladino, Jose
2011
29 38 p. 6464-6471
8 p.
artikel
27 Novel fusion protein protects against adherence and toxicity of enterohemorrhagic Escherichia coli O157:H7 in mice Gao, Xiang
2011
29 38 p. 6656-6663
8 p.
artikel
28 Patterns of in vitro cell-death, metaloproteinase-9 and pro-inflammatory cytokines in human monocytes induced by the BCG vaccine, Moreau strain Simas, C.J.A.
2011
29 38 p. 6446-6450
5 p.
artikel
29 Pekin and Muscovy ducks respond differently to vaccination with a H5N1 highly pathogenic avian influenza (HPAI) commercial inactivated vaccine Cagle, Caran
2011
29 38 p. 6549-6557
9 p.
artikel
30 Pneumococcal colonisation following influenza infection Ridda, I.
2011
29 38 p. 6444-6445
2 p.
artikel
31 Prevention of pneumonic plague in mice, rats, guinea pigs and non-human primates with clinical grade rV10, rV10-2 or F1-V vaccines Quenee, Lauriane E.
2011
29 38 p. 6572-6583
12 p.
artikel
32 Prime-boost immunisation against tropical theileriosis with two parasite surface antigens: Evidence for protection and antigen synergy Gharbi, Mohamed
2011
29 38 p. 6620-6628
9 p.
artikel
33 Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18 Yuan, Zi-Guo
2011
29 38 p. 6614-6619
6 p.
artikel
34 Responses after one dose of a monovalent influenza A (H1N1) 2009 inactivated vaccine in Chinese population—A practical observation Sun, Fuyan
2011
29 38 p. 6527-6531
5 p.
artikel
35 Response to the 2009 pandemic: Effect on influenza control in wealthy and poor countries Monto, Arnold S.
2011
29 38 p. 6427-6431
5 p.
artikel
36 Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15–59 years of age Ray, Paula
2011
29 38 p. 6592-6597
6 p.
artikel
37 Seroepidemiological study of pandemic influenza H1N1 following the 2009–2010 wave in Greece Maltezou, Helena C.
2011
29 38 p. 6664-6669
6 p.
artikel
38 The first international standard for antibodies to HPV 16 Ferguson, Morag
2011
29 38 p. 6520-6526
7 p.
artikel
39 The immune responses of HLA-A*0201 restricted SARS-CoV S peptide-specific CD8+ T cells are augmented in varying degrees by CpG ODN, PolyI:C and R848 Zhao, Kai
2011
29 38 p. 6670-6678
9 p.
artikel
40 The immunogenicity of a novel A (H1N1) vaccine in HIV-infected children Okike, Ifeanyichukwu O.
2011
29 38 p. 6636-6640
5 p.
artikel
41 Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model Liu, Kai-Yun
2011
29 38 p. 6679-6685
7 p.
artikel
42 Validity and reliability of a survey to identify vaccine-hesitant parents Opel, Douglas J.
2011
29 38 p. 6598-6605
8 p.
artikel
43 WHO Working Group discussion on revision of the WHO recommendations for the production and control of poliomyelitis vaccines (oral): TRS Nos. 904 and 910. Report of Meeting held on 20–22 July 2010, Geneva, Switzerland Martin, Javier
2011
29 38 p. 6432-6436
5 p.
artikel
                             43 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland